As the fifth variant of concern of the SARS‐CoV‐2 virus, the Omicron variant (B. 1.1. 529)
has quickly become the dominant type among the previous circulating variants worldwide …

With the great success of coronavirus disease (COVID-19) messenger ribonucleic acid
(mRNA) vaccines, mRNA therapeutics have gained significant momentum for the prevention …

Background The COVID-19 pandemic continues to pose a significant worldwide threat to
human health, as emerging SARS-CoV-2 Omicron variants exhibit resistance to therapeutic …

The rapid evolution of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
has led to the emergence of new variants with different genetic profiles, with important …

Background, Aims, Methods, Results, Conclusions: Severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is a global challenge due to its ability to mutate into variants …

The COVID-19 pandemic has driven substantial evolution of the SARS-CoV-2 virus, yielding
subvariants that exhibit enhanced infectiousness in humans. However, this adaptive …

Global spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron
subvariants, such as BA. 4, BA. 5 and XBB. 1.5, has been leading the recent wave of …

It has been nearly 35 months since the COVID-19 outbreak. The pathogen SARS-CoV-2 has
evolved into several variants. Among them, Omicron is the fifth variant of concern which …

Abstract Objectives BF. 7 (BA. 5.2. 1.7) is a novel sublineage of Omicron BA. 5, whose
clinical characteristics are not yet established. Methods From 28 September 2022 to 3 …

The continuous emergence of novel SARS-CoV-2 variants and subvariants serves as
compelling evidence that COVID-19 is an ongoing concern. The swift, well-coordinated …